ilmscore | Prediction Details
By Stock Market Live | July 30, 2024 | Pending
Interpreted Prediction
Pfizer (PFE) plans to initiate a Phase 3 program for its Cat-6 medicine within the next six months.

Prediction Details

Ticker

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.